South Korea Pharmaceuticals

OptiPharm Co Ltd (153710)

Representative Director Hyun Il Kim executed two buy transactions totaling 14.2 million KRW in September 2026. These acquisitions occurred while OptiPharm Co Ltd shares traded near their 52-week lows, reflecting an 11.7% decline over the past quarter. No selling activity was recorded during this period.
Ticker: 153710 Exchange: KOE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Hyun Il, Kim (김현일) Representative Director (대표이사) Executive Director
Transaction date
Purchase
Price
401.01
Quantity 26,469 -22.8%
Value ₩861,738
Hyun Il, Kim (김현일) Representative Director (대표이사) Executive Director
Transaction date
Purchase
Price
319.89
Quantity 10,682 +12.9%
Value ₩4,556,322
Hyun Il, Kim (김현일) Representative Director (대표이사) Executive Director
Transaction date
Purchase
Price
109.68
Quantity 60,109 -13.2%
Value ₩1,038,971
Hyun Il, Kim (김현일) Representative Director (대표이사) Executive Director
Transaction date
Purchase
Price
8,033.00
Quantity 3,311 +3.2%
Value ₩26,597,263
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-18 2026-09-18 B Purchase Hyun Il, Kim (김현일)

Representative Director (대표이사)

Executive Director
26,469 -22.8%
401.01
₩861,738 		26,469 -22.8% 401.01 ₩861,738
2026-09-18 2026-09-11 B Purchase Hyun Il, Kim (김현일)

Representative Director (대표이사)

Executive Director
10,682 +12.9%
319.89
₩4,556,322 		10,682 +12.9% 319.89 ₩4,556,322
2020-02-26 2020-02-21 B Purchase Hyun Il, Kim (김현일)

Representative Director (대표이사)

Executive Director
60,109 -13.2%
109.68
₩1,038,971 		60,109 -13.2% 109.68 ₩1,038,971
2020-02-26 2020-02-20 B Purchase Hyun Il, Kim (김현일)

Representative Director (대표이사)

Executive Director
3,311 +3.2%
8,033.00
₩26,597,263 		3,311 +3.2% 8,033.00 ₩26,597,263
Explore more

More insider trading research around OptiPharm Co Ltd

More insider trades in South Korea
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Asia-Pacific